// App-Quantinova.ai

P339 : BOOSTING THE EFFICACY OF CD20-TARGETING IMMUNOTHERAPY IN B CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Researchers

Presenter

  • Martyna Poprzeczko

Principal Investigators

  • Krzysztof Domka

  • Agata Pastorczak

  • Klaudyna Fidyt

  • Lukasz Komorowski

  • Magdalena Winiarska

  • Agnieszka Dabkowska

  • Karolina Siudakowska

  • Alicja Wojciechowska

  • Elzbieta Patkowska

  • Malgorzata Firczuk

Medical Centers

  • Department of Pediatric Cardiology and Rheumatology, Medical University of Lodz, Lodz, Poland

  • Laboratory of Immunology,Mossakowski Medical Research Institute Polish Academy of Sciences,Warsaw,Polonia

  • Department of Hematology, Institute of Hematology and Transfusion Medicine, Warszawa,

  • Laboratory of Immunology,Mossakowski Medical Research Institute Polish Academy of Sciences,Warsaw,Polonia

  • Deaprtment of Hematology,Institute of Hematolog

  • Department of Hematology, Institute of Hematology and Transfusion Medicine, Warszawa,

  • Laboratory of Immunology,Mossakowski Medical Research Institute Polish Academy of Sciences,Warsaw,Polonia

  • Department of Hematology, Institute of Hematology and Transfusion Medicine, Warszawa,

  • Department of Pediatric Cardiology and Rheumatology, Medical University of Lodz, Lodz, Poland

  • Neurology, Medical University of South Carolina

  • Laboratory of Immunology,Mossakowski Medical Research Institute Polish Academy of Sciences,Warsaw,Polonia

  • Department of Hematology, Institute of Hematology and Transfusion Medicine, Warszawa,

  • Department of Pediatric Cardiology and Rheumatology, Medical University of Lodz, Lodz, Poland

  • Dept. of Immunology, Medical University of Warsaw, Warsaw, Poland

  • Department of Pediatric Cardiology and Rheumatology, Medical University of Lodz, Lodz, Poland

  • Dept. of Immunology, Medical University of Warsaw, Warsaw, Poland

  • Dept. of Immunology, Medical University of Warsaw, Warsaw, Poland

  • Department of Pediatrics, Oncology and

  • Dept. of Immunology, Medical University of Warsaw, Warsaw, Poland

Locations

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

Biomarkers

  • Natural Killer cells

  • Peripheral blood mononuclear cell

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved